Compounding Pharmacies

Legal Issues: Compounded Care

The intended role and new classifications for compounding pharmacies.
MedEsthetics Jan/Feb 2018 Legal Issues

In 2012, 64 patients died and an additional 751 were injured due to contaminated compounded medications formulated and distributed by the New England Compounding Center. As a result, compounding pharmacies have become the subject of intense public and regulatory scrutiny, and the U.S. Food & Drug Administration (FDA) created a new two-tiered regulatory framework to improve oversight of these facilities.